Trial intelligence / Profile preview

Remimazolam vs propofol for postoperative recovery in elderly patients with fragile brain function under BIS guidance

ChiCTR2500095177Phase 4Not yet recruiting

Sponsor
Affiliated Hospital of Southwest Medical University
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in confusion comparing Remimazolam Group with Propofol Group (2 arms). Primary endpoint: Postoperative quality of recovery score (QoR). Planned start Jan 2025; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

confusion

Beyond the preview

Go deeper on ChiCTR2500095177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500095177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call